Eli Lilly and Company has appointed Thomas J. Fuchs, Dr.sc., as its first chief AI officer, effective Oct. 21, 2024.   In this role, Fuchs will provide vision, strategic direction and overall leadership of AI initiatives across Lilly, including drug discovery, clinical trials, manufacturing, commercial activities and internal functions. He will also identify, build and manage AI and machine learning solutions to help Lilly provide medicines to patients around the world.   Read More: Learn ho...